1AD — Adalta Share News
0.000.00%
Last trade - 00:00- AU$9.18m
- AU$7.60m
- AU$0.70m
Brief: Adalta Ltd Seeks Trading Halt
Brief: Adalta Says A$1.87 Million Raised In Oversubscribed Shortfall Facility
Australia's Adalta soars on promising data from drug clinical study
Brief: Adalta Ltd Says Received Approval To Commence A Phase I Extension Clinical Study Of AD-214
Australia's Adalta rises on collaboration with S.Korean biopharmaceutical co
Brief: Adalta Says Co & GPCR Therapeutics Collaborate To Evaluate New Cancer Treatment Approach Combining Beta Blockers Plus Co's CXCR4-Inhibiting I- Bodies
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 10:01:08
Australia Stock Exchange release from ADALTA : 1.6M Second Tranche R&D Cash Flow Loan Received
Australia Stock Exchange release from ADALTA : Chinese patent granted for AD-214
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:35:59
Australia Stock Exchange release from ADALTA : Half Yearly Report and Accounts
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 09:59:13
Australia Stock Exchange release from ADALTA : Adjustment to Option Exercise Prices
Australia Stock Exchange release from ADALTA : Change in Director Interest Notice x 4
Australia Stock Exchange release from ADALTA : Application for quotation of securities - 1AD
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 11:02:49
Australia Stock Exchange release from ADALTA : Entitlement Offer Results
Australia Stock Exchange release from ADALTA : PRE_NR Ends: 08:55:12
Australia Stock Exchange release from ADALTA : Quarterly Appendix 4C and Activities Report